Man who grew breasts from autism drug awarded £6,550,000,000 payout

A man has been awarded a huge payout after drugs he took for schizophrenia and bipolar disorder made him grow breasts.

Johnson & Johnson and Janssen Pharmaceuticals were blamed for failing to warn people of the side effect of taking the psychiatric drug Risperdal.

Nicholas Murray took the case to a court in Philadelphia where a jury ruled that J&J must pay $8 billion (£6.55 billion) to him.

He took the drug as a child to help him sleep because he suffered as a result of his autism.

However, the company challenged that ruling saying it was ‘grossly disproportionate’ compared to the initial award of $680,000 (£557,000) in 2015.

J&J said in a statement: ‘The company is confident (the ruling) will be overturned and will be immediately moving to set aside this excessive and unfounded verdict.’

In the statement, Johnson & Johnson accused the court of preventing their defence team from presenting ‘key evidence’ on Risperdal labelling.

The added: ‘This award for a single plaintiff stands in stark contrast with the initial $680,000 compensatory award and is a clear violation of due process.

‘United States Supreme Court precedent dictates that punitive damages awards that are a double-digit multiplier of the compensatory award should be set aside.’

Crucial quote: “This jury, as have other juries in other litigations, once again imposed punitive damages on a corporation that valued profits over safety and profits over patients. Johnson & Johnson and Janssen chose billions over children,” Murray’s lawyers said in a statement.

The company is facing a series of complaints in state courts for failing to properly warn of Risperdal’s side effects, including in Pennsylvania, California and Missouri.

Risperdal, approved for the treatment of adults by the US Food and Drug Administration in 1993, brought in some $737 million (£603 milllion) in sales in 2018.

Got a story for Metro.co.uk?

Get in touch with our news team by emailing us at [email protected] For more stories like this, check our news page.

Source: Read Full Article